BA
DRTX

BlackRock Advisors’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

BlackRock Advisors’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,315
Closed -$80K – 3804
2014
Q3 		$80K Sell
6,315
-229
-3% -$3.42K ﹤0.01% 3122
2014
Q2 		$111K Sell
6,544
-169
-3% -$2.52K ﹤0.01% 3001
2014
Q1 		$90K Buy
6,713
+389
+6% +$5.09K ﹤0.01% 3078
2013
Q4 		$81K Buy
6,324
+327
+5% +$3.43K ﹤0.01% 3128
2013
Q3 		$54K Hold
5,997
– – ﹤0.01% 3165
2013
Q2 		$43K Buy
+5,997
New +$44K ﹤0.01% 3197

BlackRock Advisors's DRTX Position: Q4 2014 in Review

BlackRock Advisors sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 6,315 shares — an estimated $80K sold.

BlackRock Advisors first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $111K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • BlackRock Advisors reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • BlackRock Advisors sold 6,315 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $80K.
  • BlackRock Advisors first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • BlackRock Advisors's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $111K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on BlackRock Advisors's 13F filing for Q4 2014, filed 9 Feb 2015.